The current authors done an open up-label pilot analyze that administered psilocybin to fifteen therapy-resistant tobacco/nicotine-dependent smokers, during the context of cognitive behavioral therapy for using tobacco cessation [58]. Participants had been administered ~0.29 mg/kg oral psilocybin about the participant’s concentrate on day to Give